Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594906 · ClinicalTrials.gov registry record · NA
Use of Teriparatide to Accelerate Fracture Healing
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00594906 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 10 participants.
The verdict
NCT00594906, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of the drug teriparatide to the effect of placebo on pelvic fracture healing.
Interventions
- DRUG Placebo
- DRUG Teriparatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00594906
The ClinicalTrials.gov registry entry for NCT00594906 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00594906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00594906 about?
NCT00594906 is a clinical study titled "Use of Teriparatide to Accelerate Fracture Healing". The purpose of this study is to compare the effect of the drug teriparatide to the effect of placebo on pelvic fracture healing.
What is the current status of trial NCT00594906?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2008-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00594906?
The interventions under investigation include: Placebo (DRUG), Teriparatide (DRUG).
Who is sponsoring clinical trial NCT00594906?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.